Christi Shaw

Insider Reports History

Location
Lilly Corporate Center, Indianapolis, IN
Signature
By: /s/ Christine Bellon, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Christi Shaw:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Avantor, Inc. Director Common Stock 36.3K $828K $22.83 May 11, 2023 Direct
Beam Therapeutics Inc. Director Stock Option (Right to Buy) 33.7K $564K $24.40 Jun 4, 2025 Direct
Kyverna Therapeutics, Inc. Director Common Stock 16.6K $35.1K $2.11 May 29, 2025 Direct
Kyverna Therapeutics, Inc. Director Stock Option (right to buy) 65.4K May 29, 2025 Direct

Insider Reports Filed by Christi Shaw

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BEAM Beam Therapeutics Inc. Jun 4, 2025 1 $0 4 Jun 6, 2025 Director
KYTX Kyverna Therapeutics, Inc. May 29, 2025 2 $0 4 Jun 2, 2025 Director
KYTX Kyverna Therapeutics, Inc. Feb 14, 2025 1 $0 4 Feb 19, 2025 Director
KYTX Kyverna Therapeutics, Inc. Sep 16, 2024 1 $0 4 Sep 18, 2024 Director
KYTX Kyverna Therapeutics, Inc. Sep 16, 2024 0 $0 3 Sep 18, 2024 Director
BEAM Beam Therapeutics Inc. Jun 5, 2024 1 $0 4 Jun 7, 2024 Director
BEAM Beam Therapeutics Inc. Dec 13, 2023 1 $0 4 Dec 14, 2023 Director
BEAM Beam Therapeutics Inc. Dec 13, 2023 0 $0 3 Dec 14, 2023 Director
AVTR Avantor, Inc. May 11, 2023 1 $0 4 May 15, 2023 Director
AVTR Avantor, Inc. May 12, 2022 1 $0 4 May 16, 2022 Director
AVTR Avantor, Inc. Apr 1, 2022 1 $0 4 Apr 5, 2022 Director